Founded in June 2022, APDM Pharmaceuticals emerged as a bold vision of visionary entrepreneurs and seasoned scientists determined to reshape the pharmaceutical landscape. With a commitment to cutting-edge innovation, uncompromising quality, and ethical partnerships, we rapidly positioned ourselves as a dynamic force in the industry.
Within just 15 months, we established a state-of-the-art 15,000-square-meter facility near Ahmedabad, marking a significant milestone in our journey to create a world-class, research-driven organization. By mid-2023, our advanced R&D center was operational, staffed with a highly skilled team of 50+ scientists specializing in formulation development, patent landscaping, and global regulatory compliance.
We aim to
To create a future-ready healthcare ecosystem driven by:
Inception of APDM Pharmaceuticals by a distinguished team of industry veterans and visionary leaders, marking the beginning of a transformative journey dedicated to pioneering healthcare innovations and pharmaceutical excellence on a global scale.
Successful procurement of prime industrial land strategically chosen to support expansive infrastructure development, future growth, and optimized operational efficiencies for APDM Pharmaceuticals.
Initiation of construction activities on APDM’s state-of-the-art pharmaceutical manufacturing facility, emphasizing adherence to global regulatory standards, sustainability practices, and cutting-edge design for superior production capabilities.
Launch of a dedicated Contract Development Organization (CDO) and sophisticated Research and Development Centre, staffed by an expert team of over 50 seasoned scientists, laying the foundation for groundbreaking innovations, drug development, and next-generation pharmaceutical solutions.
Official operational commencement of APDM’s advanced R&D Centre and CDO, actively engaged in intensive research projects, drug formulation advancements, and developmental initiatives poised to elevate healthcare solutions globally.
Strategic expansion and augmentation of research and development facilities, enhancing APDM’s scientific capabilities, technological infrastructure, and fostering greater innovation to accelerate pharmaceutical breakthroughs.
Intensified construction activities on the manufacturing facility coupled with the meticulous procurement of essential capital equipment (CAPEX), ensuring readiness for large-scale, high-quality pharmaceutical production.
Successful completion and readiness of APDM’s main manufacturing facility, built to stringent international standards, ready to house advanced production technologies and ensure compliance with global regulatory requirements.
Commencement of comprehensive machinery installation, incorporating advanced pharmaceutical technologies such as Wurster coaters, Extruders, and Spheronizers.
Formal inauguration and commissioning of APDM’s fully-equipped, regulatory-compliant manufacturing plant. Acquisition of two Abbreviated New Drug Applications (ANDAs), strategically positioning the company for accelerated regulatory approvals from international agencies including the USFDA, EMEA, and PIC/S, significantly expanding APDM’s global market reach and distribution capabilities.
Our facility boasts IoT-driven machinery and automated utilities, ensuring consistent quality and real-time data monitoring for unparalleled precision and efficiency. We’ve deliberately crafted a flexible environment that can handle everything from small-scale R&D prototypes to high-volume commercial batches, making us a versatile partner for diverse pharmaceutical needs.
